Zobrazeno 1 - 10
of 304
pro vyhledávání: '"Dai hong Liu"'
Autor:
Yu-Xin Wang, An Wang, Yong-Feng Su, Jun Wang, Yu-Hang Li, Fei Li, Yu Jing, Lei Xu, Yi-Zhi Wang, Xuan Zheng, Chun-Ji Gao, Liang-Ding Hu, Xiao-Ning Gao, Dai-Hong Liu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThe prognosis of relapsed/refractory acute myeloid leukemia (r/rAML) is dismal, and allogeneic hematopoietic stem cell transplant (allo-HSCT) is a potential cure. Combining anti-PD-1, hypomethylating agent (HMA), and CAG (cytarabine, acla
Externí odkaz:
https://doaj.org/article/4d92885038114fa3ad788dcad2eb292d
Autor:
Yu Wang, Lu Wang, Chao Ma, Peng Chen, Ning Lu, Jishan Du, Jiaojun Sun, Xu Qilong, Liping Dou, Dai-Hong Liu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Background Cytomegalovirus (CMV) reactivation after unmanipulated haploidentical stem cell transplantation (SCT) frequently occurs, causing life-threatening morbidities and transplantation failure. Pre-emptive therapy upon the detection of CMV viremi
Externí odkaz:
https://doaj.org/article/ec07bc43639e479dbeb97757a1d04c96
Autor:
Philipp Berning, Norbert Schmitz, Maud Ngoya, Hevé Finel, Ariane Boumendil, Fengrong Wang, Xiaojun Huang, Olivier Hermine, Laure Philippe, Lucile Couronné, Arnaud Jaccard, Dai-Hong Liu, Depei Wu, Christian Reinhardt, Yves Chalandon, Eva Wagner-Drouet, MI Kwon, XI Zhang, Ben Carpenter, Ibrahim Yakoub-Agha, Gerald Wulf, Francisco Lopez Jimenez, Jaime Sanz, Hélène Labussiere Wallet, Avichai Shimoni, Peter Dreger, Anna Sureda, Won-Seog Kim, Bertram Glass
Publikováno v:
HemaSphere, Vol 7, p e4059825 (2023)
Externí odkaz:
https://doaj.org/article/baf0a01b2fac4cb0898cc6b4180fd10f
Autor:
Yujun Wei, Kun Qian, Lili Wang, Fei LI, Nan Wang, Bo Peng, Yanan Wen, Lu Wang, Lingmin Xu, Xiangshu Jin, Liping Dou, Dai-Hong Liu
Publikováno v:
HemaSphere, Vol 7, p e54514e6 (2023)
Externí odkaz:
https://doaj.org/article/5f8004e779db4076b80a7354e1fd94ed
Publikováno v:
HemaSphere, Vol 7, p e8605085 (2023)
Externí odkaz:
https://doaj.org/article/dc914c4663044fa3b6680360402413bf
Autor:
Xiao-hui Zhang, Jing Chen, Ming-Zhe Han, He Huang, Er-lie Jiang, Ming Jiang, Yong-rong Lai, Dai-hong Liu, Qi-Fa Liu, Ting Liu, Han-yun Ren, Yong-Ping Song, Zi-min Sun, Xiao-wen Tang, Jian-min Wang, De-pei Wu, Lan-ping Xu, Xi Zhang, Dao-bin Zhou, Xiao-jun Huang
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-20 (2021)
Abstract The consensus recommendations in 2018 from The Chinese Society of Hematology (CSH) on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation (allo-HSCT) facilitated the standardization o
Externí odkaz:
https://doaj.org/article/0888f470080e4c5f9d96fc5f09be3e84
Autor:
Zhen-Yang Gu, Yu-Jun Dong, Xiao-Rui Fu, Nai-Nong Li, Yao Liu, Xiao-Xiong Wu, Yi-Ni Wang, Yu-Hang Li, Han-Yun Ren, Ming-Zhi Zhang, Xiao-Fan Li, Mai-Hong Wang, Ya-Mei Wu, Dai-Hong Liu, Zhao Wang, Liang-Ding Hu, Wen-Rong Huang, Peng Lyu
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 13, Pp 1584-1592 (2021)
Abstract. Background:. There were few studies on real-world data about autologous hematopoietic stem cell transplantation (auto-HSCT) or allogeneic HSCT (allo-HSCT) in peripheral T-cell lymphoma (PTCL). This study aimed to investigate the clinical ou
Externí odkaz:
https://doaj.org/article/3feb198c594d4ca7b1d968b927c70681
Autor:
Yuan-Kai Shi, Xiao-Nan Hong, Jian-Liang Yang, Wei Xu, Hui-Qiang Huang, Xiu-Bin Xiao, Jun Zhu, Dao-Bin Zhou, Xiao-Hong Han, Jian-Qiu Wu, Ming-Zhi Zhang, Jie Jin, Xiao-Yan Ke, Wei Li, De-Pei Wu, Shen-Miao Yang, Xin Du, Yong-Qian Jia, Ai-Chun Liu, Dai-Hong Liu, Zhi-Xiang Shen, Lian-Sheng Zhang, Leonard James, Edward Hellriegel, Peng Lyu
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 11, Pp 1299-1309 (2021)
Abstract. Background:. Bendamustine was approved in China on May 26th, 2019 by the National Medical Product Administration for the treatment of indolent B-cell non-Hodgkin lymphoma (NHL). The current study was the registration trial and the first rep
Externí odkaz:
https://doaj.org/article/2e136575615e46fc9bd3c8c49fd5d2b5
Autor:
Bo Peng, Li-Li Wang, Li-Ping Dou, Fei Li, Xiang-Shu Jin, Lu Wang, Ming-Yu Jia, Yan Li, Jian Bo, Yu Zhao, Hai-Yan Zhu, Wen-Rong Huang, Dai-Hong Liu, Peng Lyu.
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 12, Pp 1431-1440 (2021)
Abstract. Background:. The impacts of previous cardio-cerebrovascular disease (pre-CCVD) on the outcomes of hematopoietic cell transplantation (HCT) are not well described. Patients with pre-CCVD may often be poor candidates for HCT. This study aimed
Externí odkaz:
https://doaj.org/article/a2a6e1c52427415fa8da1ccdc49f7d85
Autor:
Hao Wang, Yu-chen Liu, Cheng-ying Zhu, Fei Yan, Meng-zhen Wang, Xiao-su Chen, Xiao-kai Wang, Bao-xu Pang, Yong-hui Li, Dai-hong Liu, Chun-ji Gao, Shu-jun Liu, Li-ping Dou
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-19 (2020)
Abstract Background Induction therapy for acute myeloid leukemia (AML) is an anthracycline-based chemotherapy regimen. However, many patients experience a relapse or exhibit refractory disease (R/R). There is an urgent need for more effective regimen
Externí odkaz:
https://doaj.org/article/0a8d09fde8b042bd8c36f15349c63609